PREVALENCE OF TRANSFUSION TRANSMISSIBLE DISEASES BETWEEN MADINAH BLOOD BANK DONORS, SAUDI ARABIA

Main Article Content

Riyad Ali Al-Ahmadi
Alaa Assad Bukhari
Ahmed Mousa Alsharyfi
Fayez Hadhrm Alsihli
Sultan Abdulhadi Sanosi
Ahmed Adil Sahlool
Abdulrahman Alanizi
Abdullah Barrak Almutairi
Mohammad Ali Albalwi
Bandar AlAhmadi
Bader Ali AlAhmadi

Keywords

Blood Bank, Blood Donor, Transfusion-Transmissible Diseases, serology

Abstract

Objective: The possible risk of TTD caused by blood-borne pathogens is one of the most undesirable risks of blood transfusion worldwide. This study aimed to screen TTD carriage and prevalence in Madinah blood bank donors and to describe the dominant TTD in the study area within Al-Madinah city. The study also aimed to provide an examination over time of the prevalence of TTDs for three years 2020, 2021 and 2022, at Al-Madinah blood banks and compare validated results obtained from previous studies with our study results.


Methods: The testing method included screening serological tests for TTDs and confirmation assays according to each pathogen. The samples were collected and tested according to guidelines approved by the AABB, CBAHI and Saudi FDA. The study subjects were 104538 male and female volunteers and replacement donors aged 18 to 60 years who donated blood from 2020 to 2022 at five blood banks within Al-Madinah city. Donor samples were tested, abnormal TTDs results were further tested for confirmation, and all results were documented according to the following policy.


Results: A total of 104538 donors, 1061 donors giving abnormal serology results for at least one marker, had an overall carriage rate of 1.01%, and only 416 were confirmed by the approved confirmation method. Out of 1061 serology-positive donors, 334, 305, 214, 105 and 103 donors were positive for HBV, HCV, syphilis, HIV and HTLV infection, respectively.


HBV was the dominant TTDs  marker, with an incidence rate of 31.47%, over other positively screened TTDs.

Abstract 324 | Pdf Downloads 93

References

1. Aabdien, Mohamed, et al. "Prevalence and trends of transfusion transmissible infections among blood donors in the State of Qatar, 2013–2017." BMC Infectious Diseases 20.1 (2020): 1-9.‏
2. Abdelaziz, Mohamed. "Prevalence of Transfusion Transmissible Infection among Healthy Blood Donors at Dongola Specialized Hospital, Sudan, 2010–2015." Sudan Journal of Medical Sciences (SJMS) (2020).‏
3. Abdo, Ayman A., Faisal M. Sanai, and Faleh Z. Al-Faleh. "Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?." Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association 18.6 (2012): 349.‏
4. Abdullah, Saleh Mohammed. "Prevalence of hepatitis B and C in donated blood from the Jazan region of Saudi Arabia." The Malaysian journal of medical sciences: MJMS 20.2 (2013): 41.‏
5. Akinbami, Akinsegun A., et al. "Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria." BMC Research Notes 5.1 (2012): 1-5.‏
6. Alabdulmonem, Waleed, et al. "Sero-prevalence ABO and Rh blood groups and their associated Transfusion-Transmissible Infections among Blood Donors in the Central Region of Saudi Arabia. "Journal of Infection and Public Health 13.2 (2020): 299-305.
7. Alaidarous, Mohammed, et al. "The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia." Journal of infection and Public Health 11.5 (2018): 702-706.‏
8. Alzahrani, Faisal Mousa, et al. "Prevalence of hepatitis B virus (HBV) among blood donors in Eastern Saudi Arabia: results from a five-year retrospective study of HBV seromarkers." Annals of laboratory medicine 39.1 (2019): 81.‏
9. Babanejad, Mehran, et al. "The HBsAg Prevalence among blood donors from Eastern Mediterranean and Middle Eastern countries: a systematic review and meta-Analysis." Hepatitis monthly 16.3 (2016).‏
10. Bamaga, Mohammad S., et al. "Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks." Saudi Med J 30.11 (2009): 1416-21.‏
11. Bhuiyan, M. N. Z., et al. "A study on screening of blood donors for seroprevalence of transfusion transmitted infections at Transfusion Medicine department of Armed Forces Institute of Pathology (AFIP), Dhaka." Bioresearch Communications-(BRC) 6.1 (2020): 815-822.‏
12. Bihl, Florian, et al. "Transfusion-transmitted infections." Journal of translational medicine 5.1 (2007): 1-11.‏
13. Bobde, Vedita, et al. "Seroprevalence of viral transfusion transmitted infections among blood donors at a government hospital blood bank in central India." Health 3.1 (2015).‏
14. Dodd, Roger Y., et al. "Development of a multisystem surveillance database for transfusion‐transmitted infections among blood donors in the United States." Transfusion 56.11 (2016): 2781-2789.‏
15. El Beltagy, Kamel E., et al. "Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia." International journal of infectious diseases 12.5 (2008): 495-499.‏
16. Elbjeirami, W., et al. "Prevalence and trends of common transfusion transmitted infections using serological and nucleic acid markers in Saudi Blood Donors." J Blood Disord Transfus 6.3 (2015): 1000280.‏
17. Gader, Abdel Galil M. Abdel, et al. "Attitude to blood donation in Saudi Arabia." Asian journal of transfusion science 5.2 (2011): 121.‏
18. Ghaleb, Yasser Ahmed, et al. "Prevalence and Associated Factors with Transfusion-Transmitted Infections among Blood Donors at the National Blood Transfusion and Research Center, Sana’a, Yemen." (2020).‏
19. Hakami, Nora Yahia. "The Most Common Causes of Transfusion-Transmitted Diseases among Blood Donors in the Middle Eastern States. "‏
20. Hanif, Farah, et al. "A Study of Blood Donor Deferral Causes: Pre vs Post Donation and Transfusion Transmissible Infections." Journal of Hematology and Stem Cell Research 2.1 (2022): 13-18.‏
21. Heyredin, Ibrahim, Bezatu Mengistie, and Fitsum Weldegebreal. "Sero-prevalence of transfusion-transmittable infections and associated factors among blood donors in Eastern Ethiopia: An Institutional-based cross-sectional study." SAGE Open Medicine 7 (2019): 2050312119834468.‏
22. Ibrahim, Essam H., et al. "Hepatitis B vaccine reduced the prevalence of antibodies to hepatitis B core antigen in blood donors in Aseer region, Saudi Arabia." Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology 6.1 (2014): 13-22.‏
23. Kleinman, Steven H., Nico Lelie, and Michael P. Busch. "Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion." Transfusion 49.11 (2009): 2454-2489.‏
24. Kurdi, Mohiadeen, et al. "Molecular detection of hepatitis B virus (HBV) among voluntary ELISA positive blood donors in Almadinah Almunawwarah." Journal of Taibah University Medical Sciences 9.2 (2014): 166-170.‏
25. Li, Changqing, et al. "Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four Chinese regional blood centers between 2000 and 2010." Journal of translational medicine 10.1 (2012): 1-10.‏
26. Majid, Fahad AL. "Prevalence of transfusion-transmissible infections among blood donors in Riyadh: A tertiary care hospital-based experience." Journal of Nature and Science of Medicine 3.4 (2020): 247.‏
27. Mudasar, Muhammad, et al. "An epidemiological study for seroprevalence of transfusion transmissible infections among blood donors in Faisalabad, Pakistan." Rawal Medical Journal 45.3 (2020): 531-531.‏
28. Patil, Pooja U., Suresh Gawai, and Anil Joshi. "Seroprevalence of transfusion transmitted infections among blood donors: An 8 year regional blood bank experience." Galore International Journal of Health Sciences and Research 5.1 (2020): 150-154.‏
29. Pessoni, Lívia Lara, Érika Carvalho de Aquino, and Keila Correia de Alcântara. "Prevalence and trends in transfusion-transmissible infections among blood donors in Brazil from 2010 to 2016." Hematology, transfusion and cell therapy 41 (2019): 310-315.‏
30. Redwan, N. A., M. M. Ahmed, and M. B. Barnawi. "Prevalence study of Hepatitis B virus (HBV) infection by serological techniques in Jeddah, Saudi Arabia." Life Sci J 9.4 (2012): 5442-8.‏
31. Sarah, Yousef Abd El Galil Ahmed, and A. L. Ali. "Seropositivity of TTIs among blood donors in Hail, Saudi Arabia, from 2014 to 2015." Asian Pacific Journal of Tropical Disease 6.2 (2016): 141-146.‏
32. Steele, Whitney R., et al. "Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion‐Transmissible Infections Monitoring System (TTIMS). "Transfusion 60.10 (2020): 2327-2339.‏
33. Sundaramoorthy, Raja, et al. "Seroprevalence of transfusion transmissible infections among blood donors by chemiluminescent assay in a tertiary care center." The Journal of Infection in Developing Countries 12.01 (2018): 031-036.‏
34. Thakur, Ramu, et al. "The prevalence of transfusion transmitted infections in a tertiary care center." European Journal of Molecular and Clinical Medicine 8.4 (2021): 2463-2467.‏
35. World Health Organization. Blood donor selection: guidelines on assessing donor suitability for blood donation. World Health Organization, 2012.‏